Trial Profile
A prospective, randomized intra-individual study with the sirolimus coated cypher select(TM) and the paclitaxel(TM) coated express balloon expandable stents for the treatment of patients with two de novo native coronary artery lesions.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Paclitaxel
- Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms FRE-RACE
- 20 May 2009 Planned number of patients changed from 110 to 112, additional lead trial centre University Hospital Freiburg and lead trial investigator Manfred Zehender as reported by ClinicalTrials.gov.
- 20 May 2009 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
- 20 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials. gov.